Galaxy Medicare Ltd
₹
None%
- close price
About
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]
Key Points
- Market Cap ₹ 81.9 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 24.3
- Book Value ₹
- Dividend Yield %
- ROCE 17.7 %
- ROE 15.8 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 28.57 | 30.94 | 35.84 | 39.20 | |
| 26.41 | 28.59 | 30.87 | 34.55 | |
| Operating Profit | 2.16 | 2.35 | 4.97 | 4.65 |
| OPM % | 7.56% | 7.60% | 13.87% | 11.86% |
| 0.50 | 1.72 | 1.18 | 1.07 | |
| Interest | 0.80 | 0.95 | 0.94 | 0.69 |
| Depreciation | 0.82 | 1.12 | 0.48 | 0.50 |
| Profit before tax | 1.04 | 2.00 | 4.73 | 4.53 |
| Tax % | 30.77% | 21.50% | 21.56% | 25.61% |
| 0.72 | 1.57 | 3.71 | 3.37 | |
| EPS in Rs | ||||
| Dividend Payout % | 9.72% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 16% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 2.80 | 3.04 | 11.86 | |
| Reserves | 12.88 | 14.78 | 9.51 | |
| 8.78 | 9.15 | 8.12 | ||
| 5.44 | 5.34 | 3.05 | ||
| Total Liabilities | 29.90 | 32.31 | 32.54 | |
| 13.95 | 14.57 | 14.41 | ||
| CWIP | 0.20 | 0.06 | 0.00 | |
| Investments | 2.98 | 2.69 | 3.11 | |
| 12.77 | 14.99 | 15.02 | ||
| Total Assets | 29.90 | 32.31 | 32.54 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 5.56 | 3.65 | 2.71 | 4.40 | |
| -4.46 | -1.91 | -0.65 | 0.32 | |
| -1.11 | -1.80 | -2.08 | -4.72 | |
| Net Cash Flow | 0.00 | -0.07 | -0.03 | 0.00 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 93.26 | 106.65 | 74.65 | |
| Inventory Days | 73.90 | 101.37 | 123.74 | |
| Days Payable | 101.66 | 91.77 | 32.29 | |
| Cash Conversion Cycle | 65.50 | 116.24 | 166.10 | |
| Working Capital Days | 0.51 | 36.10 | 56.83 | |
| ROCE % | 18.53% |
Business Profile[1]
Galaxy manufactures, trades, and exports medical devices with a focus on POP bandages, medical tapes, surgical dressings, and wound care products. It operates through its own brands, OEM supply, government/institutional sales, exports, and trading channels.